Found 37 matching trials
Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas
PHASE1Trial evaluating the efficacy of regorafenib combined with irinotecan compa...
Location
Institut de Cancérologie de l'Ouest-Paul Papin
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
PHASE2The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Location
Istituto Nazionale Tumori | "Fondazione Pascale"
CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen
PHASE2This clinical program aims to evaluate the activity and efficacy of cetuxim...
Status
Active Not Recruiting
Location
A.O.U. Ospedali Riuniti
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
NAThe investigators propose to conduct a single-center, single-arm, Phase I c...
Status
Active Not Recruiting
Location
Colorectal Cancer, West China Hospital
A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)
PHASE1This is an open-label, single center, non-randomized, phase Ⅱ trial to eval...
Location
Zhejiang Province Cancer Hospital
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
PHASE2The study is an interventional Phase II clinical trial aiming to optimize i...
Location
Beijing Cancer Hospital
RegoNivo vs Standard of Care Chemotherapy in AGOC
PHASE3To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Location
Mayo Clinic Arizona
The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
PHASE3This is a randomized, open-label, multicenter, phase III clinical study. Th...
Location
Multiple Locations
Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
PHASE3This study is a multicentre, prospective, randomised trial, aims to evaluat...